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Summary.-Plasminogen activator of cell origin converts the plasma protein
plasminogen to the proteolytic enzyme plasmin. Recently, high levels of activator
have been observed to be particularly associated with tumours and transformed
cells, and a functional relationship between plasminogen activation and malignancy
has been proposed. In this paper we have attempted to induce transformation-like
morphology and growth in a population of confluent quiescent cells in tissue culture,
by inducing plasminogen activation. Untransformed 3T3 cells grown to confluence in
plasminogen-free medium were subjected to plasminogen activation by the addition
of urokinase and plasminogen or plasminogen-containing acid-treated serum, or
plasmin. Under these conditions, the previously well ordered monolayers became
disrupted, with multilayering, and discontinuities in the cell sheet, and the cells
simultaneously grew to significantly higher densities. Removal of the plasmin-
containing medium supplements effected some restoration of normal morphology.
Thus, when plasmin was present3T3 cells did notbecometransformed, butexpressed
transformation-like features. Well ordered monolayer morphology and quiescence
in 3T3 cells at confluence are therefore dependent upon the absence of plasminogen
activation.
PLASMINOGEN is a proenzyme which is
plentiful in blood. It is converted to the
proteolytic enzyme plasmin by a variety
of activators which include urokinase. A
number of cells secrete plasminogen acti-
vators; some of these resemble urokinase
immunologically, structurally, and in their
activation mechanism (Bernik & Kwaan,
1969; Wu et at. 1977). Activators are pre-
sent in many normal tissues (Todd, 1959;
Albrechtsen, 1959; Bachmann et al., 1964;
Bernik & Kwaan, 1967, 1969; Beers, 1975;
Sherman et al., 1976; Vassalli & Reich,
1977; Strickland & Beers, 1976; Loskutoff
&Edgington, 1977),butrecentlyhighlevels
of plasminogen activator have been par-
ticularly associated with cultured cells
derived from spontaneous and induced
tumours (Quigley et al., 1974; Wachsman
& Biedler, 1974; Laug et al., 1975; Jones
et al., 1975b; Hince & Roscoe, 1977) and
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cells transformed by a variety of agents
(Quigley et al., 1974; Jones et al., 1976;
Wigler & Weinstein, 1976; Barrett et al.,
1977; Loskutoff & Edgington, 1977).
Because ofthis and, in normal cells, the
additional association with invasiveness
(Sherman et al., 1976), the relationship of
this enzyme to transformation has been
investigated. Evidence exists for an asso-
ciation between high levels of activator
and the permissive temperature in virus-
transformed temperature-sensitive mu-
tants (Unkeless et al., 1973; Rudland et al.,
1975). Furthermore a number of features
of transformation have been shown to be
dependent upon or inducible by plasmino-
gen activator. These include transformed
morphology (Ossowski et at., 1973a, 1973b,
1974; Weber, 1975; Urquhart et al., 1978),
agglutination with plant lectins (Whur et
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anchorage dependence (Ossowski et al.,
1973b; Pollack et al., 1974; Laug et al.,
1975; Rudland et al., 1975; Kamely,
1976), metastasis (Peterson et al., 1973),
migration and invasiveness (Ossowski et
al., 1973b), altered cell adhesion (Weber,
1975) and the onset of DNA synthesis in
previously quiescent confluent mono-
layers (Urquhart et al., 1978). There are,
however, reports of an absence of correla-
tion between plasminogen activation and
malignancy or transformation (Hisazumi
& Fukushima, 1973; Mott et al., 1974;
Chibber et al., 1975), transformed morph-
ology (Chen & Buchanan, 1.975; Barrett
et al., 1977), increased hexose uptake
(Chen & Buchanan, 1975; Weber, 1975),
growth in soft agar (Jones et al,
1975c) and growth inhibition in trans-
formed cells (Chou et al., 1974; Roblin et
al., 1975).
When confluent quiescent 3T3 cells
were co-cultured with SV40-transformants
to provide plasminogen activator, they
synthesised DNA at higher rates within a
few hours (Urquhart et al., 1978). This was
associated with morphological changes
which included the appearance of gaps
between the cells. Other work has also
suggested a correlation between cell
growth and plasminogen activation;
Blumberg & Robbins (1975) initiated
growth of density-inhibited chick embryo
fibroblasts by adding streptokinase-acti-
vated plasminogen, and Chou et al. (1977)
correlated plasminogen-activator secretion
and cell multiplication in 3T3 cells. Since
correlation between plasminogen activa-
tion and the loss of density-dependent in-
hibition would be significant in postulating
a causal relationship between plasminogen
activation and loss of growth control, we
have subjected confluent quiescent 3T3
monolayers, grown in plasminogen-free
serum, to activated plasminogen. Under
these conditions the monolayers were dis-
rupted and the cells grew to higher densi-
ties. Similar but less pronounced effects
were obtained with plasminogen alone,
presumably because of activation by 3T3
cell activator.
MATERIALS AND METHODS
Cell cultures.-Swiss mouse 3T3 cells were
obtained at Passage 118 from the American
Type Culture Collection. To prevent spon-
taneous transformation, cells were subcul-
tured at low density and discarded after 12
passages. They were routinely grown in
Dulbecco's modification of Eagle's medium
(DMEM) +10% foetal calf serum, but ex-
periments were carried out in DMEM+10%
horse serum, because of its relatively high
concentration of plasminogen. Cells for the
statistical detection (P<0 05) of population
growth were grown in 96-well trays (Falcon,
Oxnard, California) and 8 or more replicate
samples, each comprising the cells from a
single well (, 0 3 cm2) were counted on a
Coulter counter. Live cells were photographed
by phase-contrast microscopy. Cells for
scanning electron microscopy were grown in
acetone-resistant disposables (Lux Scientific
Corp., Thousand Oaks, Calif.), fixed in 10/')
gluturaldehyde followed by 1% osmium
tetroxide, and critical-point-dried in situ.
Assay procedures and medium supplements.
-Plasminogen wNas removed from horse
serum by affinity chromatography on a
lysine-Sepharose column, using a modifica-
tion ofthe method ofDeutsch & Mertz (1970).
Using a modified fibrin-agarose plate assay
(Jones et al., 1975a) acid-treated serum
samples were tested for residual plasminogen
by activation with urokinase placed in a
central well. Calibration wras against standard
plates containing human plasminogen (Kabi-
Vitrum, London), which had an activity of
-15 casein units (cu)/mg of protein. Modifi-
cations of the assay were used to quantify
urokinase and plasmin. Plasminogen-free
media were supplemented with plasminogen
at a final concentration of 2 cu/ml ofmedium.
Its purity was checked by electrophoresis on
7.-50 SDS polyacrylamide gels (Bio-Rad
Laboratories, Richmond, Calif.).
In order partially to remove inhibitors of
plasminogen activation, serum was reduced
to pH 3-2 for 15 min at room temperature by
the addition of mercury-free IM HC1; 1Im
NaOH was then added to achieve pH 7-2.
Compensation for dilution was made in
subsequent media formulations.
Human urokinase (Calbiochem, San Diego,
California, 1000 Plough units (pu)/mg) was
added to cultures at a final concentration of
2 or 10 pu/ml. Nonspecific proteolytic
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activity was sought using plasminogen-free
or E-aminocaproic acid-containing (EACA,
up to 900 ,ug/ml) plates.
Human plasmin (KabiVitrum, London,
15 cu/mg of protein) was added to cultures at
a final concentration of 1 cu/ml. Its purity
wias examined by electrophoresis on 7.500
SDS-polyacrylamide gels.
Plasmin levels generated in tissue culture
from plasminogen in the presence of serum-
supplemented media, either by urokinase or
by confluent 3T3 cells alone, were assayed
over a 28h period, using the chromogenic
substrate S2251 (KabiVitrum, London), and
calibrated against a standard plasmin curve.
A more detailed account of this assay system
is in preparation.
RESULTS
Plasminogen activation in cell cultures
When run on polyacrylamide gels (Fig.
1) plasminogen migrated with an approxi-
mate mol. wt of 90,000, and plasmin at a
mol. wt of 75,000 with 2 prominent
minor bands. One of the latter migrated
with plasminogen; the other was of lower
mol. wt. There was no trace of plasmin in
the plasminogen. Plasminogen did not
cause fibrinolysis when incorporated in
fibrin-agarose plates unless urokinase was
added. Urokinase was not examined for
purity by electrophoresis, since it exists in
at least 4 active forms of widely differing
mol. wt (Astedt et al., 1977). It was, how-
ever, examined for nonspecific fibrinolysis
in plates containing no added plasminogen.
One plough unit per plate (the standard
level in the assay) produced no detectable
effect, but levels of 5 pu or aboveproduced
increasingly large zones of fibrinolysis.
However, even when 50 pu was used,
fibrinolysis was totally abolished by the
addition ofEACA at 20 ,ug per plate, or by
prior heating of the plates to 80°C for 25
min. There was no detectable inhibition
ofurokinase when it was added at 10 pu/ml
to medium supplemented with 10% plas-
minogen-free acid-treated horse serum,
and subsequently assayed on serum-free
plasminogen-containing plates. However,
when plasminogen was added at 2 cu/ml
FIc. 1. SDS-polyacrylamide-gel electro-
phoresis of plasmin and plasminogein
(KabiVitrum, London). Samples were run
with markers (Bio-Rad Laboratories, Rich-
mond, Calif.) whose approximate mol. wts
(X 10-3) are indicated. Plasminogen, in the
central tube, migrates as 2 fused bands of
about 90,000 mol. wt. Plasmin, on the
right, migrates as 2 bands of about 75,000
mol. wt, together with 2 other major bands.
One of these migrates with plasminogen,
from which the plasmin originated, the
other is an activation degradation prodluct
of about 25,000 mol. wt. There is no
evidence of plasmin in the plasminogen
sample.
to this supplemented medium, the ex-
pected degree of activation was not
achieved, because inhibitors were present.
This effect, which was presumably due to
plasmin inhibition, could not be quantified
under tissue-culture conditions for tech-
nical reasons.
The levels of plasmin generated by a
combination ofurokinase and plasminogen
in tissue culture in the presence of 10%
acid-treated plasminogen-free horse serum
are shown in Fig. 2. Plasmin was also
generated in the absence of urokinase,
indicating that the confluent 3T3 cells
produced plasminogen activator (Fig. 2).
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FIG. 2. Generation of plasmin in tissue
culture. Confluent 3T3 cells were incubated
in indicator-free DMEM supplemented
with 1000 acidl-treated plasminogen-free
horse serum and the chromogenic substrate
S2251. Plasminogen at 2 cu/ml was added to
both cultures, and urokinase at 10 ptu/ml
to one only (- ). OD readings were
converted to cui plasmin using the linear
part of a standlard curve. The results show
that plasminogen was activated to plasmin
under the culture conditions used, and t,hat
confluent 3T3 cells produced significant
amounts of plasminogeni activator
( *).
Growth and morphology of 3T3 cells
The growth rate of subconfluent 3T3
cells in media supplemented with plas-
minogen-free horse serum was identical to
that in horse serum. A reduction in growth
rate was detected after acid treatment,
irrespective of whether plasminogen had
been removed or not. Despite this, 3T3
cells readily achieved confluent densities
when grown in acid-treated supplements.
The appearance of confluent 3T3 cell
monolayers varied with the serum supple-
ment used. In horse serum the monolayers
were fairly stable and the cells were poly-
gonal in shape (Fig. 3a). In acid-treated
horse serum there were groups of
elongated cells orientated in one direction
(Fig. 3b); these monolayers were unstable
and soon exhibited changes similar to
those, described below, associated with
plasminogen activation. In plasminogen.-
free horse serum the monolayers were
stable and comprised mainly polygonal
cells (Fig. 3c), and acid-treatment of
plasminogen-free horse serum produced
no change in this appearance (Fig. 3d).
3T3 cells were grown to confluence in
medium supplemented with acid-treated
plasminogen-free horse serum and cell
density was then monitored over a 3-week
period (Fig. 4). During the first week there
was a slight but significant (P<0.05) in-
crease in cell density, but the rate of
growth continuously declined with time.
The total increase in cell density over the
22 days was small, from 2 3 x 104 to
36x 1x04 cells/cm2, and the projected
population-doubling time was 79 days.
Changes in growth and morphology associ-
ated with urokinase, plasminogen and
plasmin
At 10 pu/ml, urokinase had no effect on
the morphology of the confluent mono-
layer (Fig. 5b). There was no detectable
change in cell density from the control
(P>0 3; Fig. 4).
WVhen plasminogen was added at 2 cu/ml
to medium supplemented with plasmino-
gen-free acid-treated horse serum, changes
were seen in the morphology of the mono-
layers within a few days. They became
discontinuous, many of the cells were
elongated and there were areas of multi-
layering (Fig. 5a). These morphological
changes were accompanied by growth to a
significantly higher density than that of
the plasminogen-free control (Fig. 4).
When urokinase and plasminogen were
both added to acid-treated plasminogen-
free horse serum, the appearance of the
monolayer changed rapidly, and cell
counts became unreliable and were soon
abandoned (Fig. 4). Initially there was cell
elongation and multilayering (Fig. 5c);
subsequently disruption became more ex-
treme, and the cells formed thick cords
with large areas of the growth surface
almost devoid of cells (Fig. 5d). These
morphological changes were associated
with growth to significantly higher densi-
ties than those of the control (Fig. 4).
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FIG. 3.-3T3 cells grown to confluence in DMEM supplemented with 10% horse serum which has been
subjected to various treatments. (a) Untreated horse serum. The cells have formed a fairly stable
confluent monolayer; most are irregular but polygonal in shape, and there is a degree ofelongation
and overlapping. (b) Acid-treated horse serum, to remove most of the inhibitors of plasminogen
activation. The cells are elongated and there is evidence ofmultilayering; spaces in the monolayer
can be observed. Such monolayers were unstable and disruption became more pronounced with
time. (c) Plasminogen-free horse serum. The monolayer resembles (a) indicating that plasminogen
activation or plasmin were almost completely inhibited in (a). (d) Acid-treated plasminogen-free
horse serum. The monolayer resembles those of (a),and (c), indicating that the disruption observed
in (b) resulting from acid treatment ofwhole serum was associated with plasminogen activation and
not with acid-treatment. Bar= -100 ,um.
Similar, but even more rapid, growth was cells were elongated and exhibited multi-
seen when acid-treated horse serum was layering. These changes were associated
used instead ofplasminogen supplementa- with growth to significantly higher densi-
tion (Fig. 4). When plasmin was added at ties (Fig. 4). When the cells were returned
1 cu/ml the changes (Fig. 5e) were similar to medium containing only acid-treated
-to but less marked than those produced by plasminogen-free serum, there was a
urokinase and plasminogen together; the partial reversal of the disruption that had
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FIG. 4. Effect of supplements on the
growth of confluent 3T3 cells. The cells
were grown in DMEM supplemented with
100% acid-treated plasminogen-free horse
serum. Fresh medium was supplied every
'3 (lays throughout the experiment. The
cells achieved confluence on Day 0. Except,
in the control, the media formulations were
then supplemented in various ways.
Changes in cell (tensity were then monitored
until disruption of the monolayers became
so extreme that reliable counts coul(d no
longer be made, and with the exception of
uirokinase supplementation, where only 2
sets of readings were made, best-fit curves
wvere comptuted from these data. The corre-
lation coefficients derived from these (lata
weIe statistically significant (P<0-05) in
every case.
Control; remaining in the origiinal
me(lium formulation.
plg; Supplemented with 2 cu/ml plas-
minogen. Cell density became significantly
higher (P<0-02) than the control on
Day 9.
uk; Supplemented with 10 pui/ml uro-
kinase. Cell density indistinguishable from
that of the control (P>0-3).
plg-+uk; Supplemented with 2 cu/ml
plasminogen and 10 pu/ml urokinase. Cell
(lensity became sigrnificantly higher than
the control (P<0-05) on Day 2.
plasmin; Supplementedi with 1 cu/ml
plasmin. Cell (lerisity became significantly
higher than the control (P<0-05) on
Day 9.
Ser um+uk; original mediuim replaced by
one supplemented with 100% acid-treated
horse serum and 10 pu/ml urokinase. Cell
(lensity became significantly higher than
the conti-ol (P<0-05) on Day 2.
resulted from medium supplementation
(Figs. 5f, g).
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By supplementing the medium with 2
instead of 10 pu/mi of urokinase, in addi-
tion to plasminogen, the early effects of
plasminogen activation were slowed down
and could be examined in more detail.
Cells in medium supplemented with
urokinase alone formed well-ordered con-
fluent monolayers (Fig. 6a) with no
evidence of nuclear overlapping. In the
presence of urokinase and plasminogen
together, there was a gradual development
of isolated plaques in the monolayer
where multilayering was apparent, while
the rest of the monolayer superficially
appeared quite normal (Fig. 6b). However,
when examined by scanning electron
microscopy it was apparent that inter-
cellular fissures were a prominent feature
ofthese areas (Fig. 6c). The plaques them-
selves comprised multilayers of flattened,
loosely attached cells (Fig. 6d).
DISCUSSION
Because of substantial evidence corre-
lating high levels ofplasminogen-activator
production with certain characteristics of
transformed or malignant cells, the aim
of this investigation was to examine
the effect of plasminogen activation on
confluent quiescence, since this form of
growth control is abolished by trans-
formation. Plasminogen activation in
culture was achieved by adding urokin-
ase and plasminogen, or plasmin, to
plasminogen-free cultures, or by adding
urokinase to cultures containing plasmino-
gen. Under such circumstances confluent
quiescence was abolished; the cells grew
to significantly higher densities and the
renewed cell growth was accompanied by
marked morphological changes.
Plasminogen activation in tissue culture
In order to be certain that the observed
changes were dependent upon the activa-
tion of plasminogen, it was necessary to
confirm the reaction between urokinase
and plasminogen. This required evidence
for the purity ofplasminogen, and also for
the absence of fibrinolytic activity and
changes in cell morphology or growth
kinetics mediated by urokinase or plas-
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minogen in the absence of urokinase or
activator. In addition it was necessary to
show that urokinase/plasminogen mix-
tures did generate plasmin under the con-
ditions used for tissue culure.
In the case of urokinase there was no
evidence of nonspecific (i.e. plasminogen-
independent) fibrinolysis which could not
be attributed to traces of plasminogen in
the "plasminogen-free" fibrin, since fibrin-
olysis was abolished by EACA, or by
heating the plates to 80TC for 25 min
to remove plasminogen (Lassen, 1952).
When urokinase was added at 10 pu/ml
to confluent 3T3 cells there was no obvious
effect ontheir morphology (Figs. 5b and 6a)
or growth (Fig. 4). This was not due to
urokinase inhibition by components of the
medium, since samples of such medium
did generate fibrinolysis when plasminogen
w-as added.
The presence of plasmin in plasminogen
would have been unacceptable, because of
possible pre-urokinase activation (Bernik
& Oller, 1976), accelerated plasminogen
activation (Thorsen, 1977), and urokinase-
independent fibrinolytic activity, when
added to 3T3 cells. The human plasmino-
gen used gave a single major band in the
90,000 mol. wt region on SDS-poly-
acrylamide gels, corresponding to the
known mol. wt of plasminogen (Wallen,
1977) and indicating itspurityanddistinct-
ness from plasmin (mol. wt 76,500;
Robbins et al., 1975). The absence of
plasmin was confirmed in fibrin-agarose
assays showing that plasminogen did not
exhibit urokinase-independent fibrinolysis.
Fibrinolysis produced by the interaction
of urokinase and plasminogen was in-
hibited by the addition of EACA at about
the concentration at which it is an
effective non-competitive inhibitor ofplas-
min (Iwamoto et al., 1968), indicating that
plasmin had been generated. Plasmin was
also generated in media containing 10%-
acid-treated plasminogen-free horse serum
supplemented with 10 pu/ml urokinase
and 2 cu/ml plasminogen, confirming that
activation occurred in tissue culture
(Fig. 2). However, plasmin was also gener-
atedfrom plasminogen by 3T3 cells (Fig. 2),
indicating that they produced plasmino-
gen activator at confluence. Although
plasmin was generated much less rapidly
in the absence of urokinase, it is possible
that the total plasmin generated by 3T3
cells between medium changes (3 days)
was quite high, and sufficient to account
for the observed changes in morphology
and growth.
On SDS-polyacrylamide gels plasmin
(Fig. 1) separated into bands identified as
residual plasminogen (90,000 mol. wt),
plasmin (75,000 mol. wt) and plasminogen
degradation products (25,000 mol. wt).
The relative absence of impurities indi-
cates that the effects produced in tissue
culture by this preparation were attribu-
table to plasmin.
FTG. 5. The effect, of serum supplements on 3T3 cell monolayers. The cells were first grown to con-
fluience in me(lium supplemented with acid-treated plasminogen-free serum, which was then
supplemente(l as indicated. Bar= I100 Hm
(a) 2 cu/ml plasminogen. After 4 (lays the monolayer is no longer confluent; some of the cells
have become elongated and exhibit overlapping.
(b) 10 pu/ml urokinase. After 6 days the monolayer is unchanged.
(c) 2 cu/ml plasminogen and 10 pu/ml urokinase. After 4 days all cells are elongated and there is
considerable overlapping. Cell density appears to have increased and multilayering is apparent in
some areas of the monolayer.
(d) 2 cui/ml plasminogen andl 10 pu/ml urokinase. After 5 days the monolayer has partly detached
from the (lish, although intercellular a(lhesions generally remain intact.
(e) 1 cu/ml plasmin. After 4 days the changes resemble those prodluced by a combination of
uirokinase an(l plasminogeri.
(f) Plasminogen and urokinase. Five days after reverting to the original unsupplemented
medium, recolonization of the dish surface has begun and cells are migrating out from a raised
plaque.
(g) Plasminogen and urokinase. Ten clays after reverting to the original mediium the dlish surface
is covere(1 by a monolayer of cells an(d the plaque has partially dlisperised.
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rIG. ff. -tnects ot low levels oturokinase onconnuent 313ceus inplasminogen-supplemented medium.
In this experiment the level of urokinase was dropped from 10 to 2 pu/ml, so that the early effects
of plasminogen activation could be observed. Figs. 6a, c and d are scanning electron micrographs.
(a) Supplemented with urokinase alone. After 10 days in supplemented medium the monolayer
retains its normal appearance, the cells are mainly polygonal and there are no intercellular spaces
or nuclear overlaps. Bar= 10 tim.
(b) Supplemented with urokinase and plasminogen. After 6 days in supplemented medium much
of the monolayer remains normal in appearance, but there are discrete plaques where the cells
exhibit overlapping and multilayering. Bar= 100 Ktm.
(c) As (b). Changes in the relatively normal areas between the plaques can be seen by scanning
electronmicroscopy. Mostofthecellshave intercellular fissures down one or moresides. Bar = 100 ,m.
(d) As (b). Multilayering is clearly apparent in the plaque area. The superficial cells remain
flattened, but are partly separated from those beneath. Bar= 10 ,um.
Loss of growth inhibition in supplemented first week, but the growth rate continued
media to drop with increasing cell density (Fig.
After 3T3 cells were grown to confluence 4), indicating a gradual and continuous
in medium containing acid-treated plas- approach to total quiescence. When the
minogen-free serum we detected slow but media were supplemented with plasmino-
statistically significant growth during the gen (Fig. 5a) or plasminogen-containing
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acid-treatedl horse serum (Fig. 3b), the
monolayers were unstable and the cells
grew to significantly higher densities
(Fig. 4). Since depletioii of plasminogen
had no effect on the growth rate of 3T3
cells at subconfluence this effect was not,
due to the ability of plasminogen to
initiate a more rapid growth rate in
dividing 3T3 cells, but, was associated
with the abolition of density-dependent
inhibition. The plasminogen used was pure
and failed to exhibit fibrinolysis; the effect
produced by adding plasminogen alone is
therefore attributable to its activation to
plasmin by 3T3-cell activator (Fig. 2).
Urokinase alone had no detectable
effect on the growth of confltuent, 3T3 cells
(Fig. 4) but when added together with
plasminogen or with acid-treated horse
serum there was growth to significantly
higher densities. Since plasminogen was
activated to plasmin under these condi-
tions (Fig. 2), this effect is also attributable
to the action ofplasmin on the monolayer.
The addition of 1 cu/ml of plasmin to
quiescent, cells in plasminogen-free media
also caused growth to significantly higher
densities (Fig. 4).
The data on growth kinetics indicate
that plasmin abolished density-dependent
inhibition of cell growth in confluent
quiescent 3T3 cells, and caused them to
grow to abnormally high densities. Thus
density-dependent inhibition of growth in
3T3 cells requires the absence of effective
plasminogen activation, and transforma-
tion associated with a significant increase
in activator production would therefore
abolish growth control. Chou et al. (1977)
have provided detailed evidence that con-
fluence is associated with reduced levels of
external activator in 3T3 but not SV40-
3T3 cells. Our results support their sug-
gestion that plasminogen activator is
linked to cell multiplication in untrans-
formed 3T3 cells. This effect is not ex-
clusive to plasminogen activation, since
similar effects have been produced in 3T3
cells using other proteases (Burger, 1970);
the particular significance of plasminogen
activation may lie in the high levels of
activity specifically associated with trans-
formation and malignancy.
Morpholoyical changes associated with
plasminogen activation
Confluent, contact-inihibited 3T3 cells
form a continuous cell sheet with a density
of about 5 x 104 cells/cm 2, with over-
lapping of cytoplasmic processes but no
nuclear overlap (Todaro et al., 1964).
Except for rather lower cell densities
(Fig. 4), cells grown to confluence in
medium supplemented with plasminogen-
free horse serum, with or without acid
treatment to remove inhibitors of plas-
minogen activation, fulfilled these criteria
(Figs. 3c, d). Marked chaniges in this
morphology were associated with plas-
minogen activation or plasmin. When
these changes were controlled by reducing
the degree of plasminogen activation as a
result of lowering the uirokinase concen-
tration, the monolayer remained rela-
tively intact, but there were fissures
between the cells (Fig. 6c) similar to those
described previously (Urquhart et al.,
1978) when 3T3 cells were grown in co-
culture with SV40-3T3 cells in medium
containing plasminogen. This change alone
may be sufficient to initiate growth in the
monolayer (Urquhart et al., 1978). How-
ever, not all the cells in the population
were dividing. The doubling time of our
popuilations exceeded 7 days, compared
to the normal 3T3-cell doubling time of
18 h (Todaro et al., 1964). Division may
therefore have been associated only with
those areas where multilayering subse-
quently developed (Figs. 6b, c, d).
When acid-treated media containing
plasminogen were supplemented with
higher levels of urokinase to produce more
plasmin, the monolayers became very dis-
organized. Early on the cells became
elongated and randomly orientated, with
processes clearly overlapping adjacent
cells (Fig. 5c). The monolayers then
became partlv detached with cords of
multilayered cells adjacent to cell-free
areas of the growth surface (Fig. 5d). The
early changes (Fig. 5c) may have been due
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to active migration of the cells, since
plasminogen activation does have a role
in 3T3 cell migration (Ossowski et al.,
1975). Subsequent disruption ofthe mono-
layer (Fig. 5d) was produced by partial
detachment rather than cell migration.
Zetter et al. (1976) have described similar
changes after incubating confluent chick
embryo fibroblasts with various proteases,
and they differentiate between early
effects, similar to those we observed,
attributable to the loss of a 205,000-mol.
wt surface protein, and a separate and
later migration of cells into clumps
attributable to a 250,000-mol. wt cell
surface protein. Since plasmin is not very
effective at removing this component
(Hynes, 1974), it appears that the early
elongation, multilayering and apparent
loss of contact inhibition in confluent 3T3
cells may be associated with loss of a
205,000-mol. wt or equivalent component,
and the subsequent passive clumping pro-
cess to a persistence of some of the
250,000-mol. wt protein which maintains
the adhesion between the cells. If this
interpretation is correct the effects of
plasmin are not unique, but closely re-
semble effects produced by other proteo-
lytic enzymes with a similar action such as
thrombin, bromelin and alpha-protease
(Zetter et al., 1976). The fact that the
plasmin-mediated changes are at least
partly reversible (Figs. 5f, g) indicates that
they remain plasmin-dependent, and that
transformation has not occurred.
Our findings show that density-depend-
ent inhibition of growth in confluent 3T3
cells is abolished by plasminogen activi-
tion, and indicate that contact inhibition
movement is also abolished. The plasmin-
dependent morphology which developed
in previously confluent quiescent 3T3-cell
monolayers resembled the appearance of
transformed cell populations and was
characterized by multilayering. We have
previously shown (Whur et al., 1976) that
3T3 cells became agglutinable by con-
canavalin A after plasminogen activation.
Here again the results of plasminogen
activation was to mimic the effects of
transformation. This suggests that cells
producing activator may exhibit charac-
teristics associated with transformation
under conditions where plasmin can be
generated. However, not all cells pro-
ducing activator are malignant; many
have physiological roles, for example, in
blood defibrinating mechanisms, ovula-
tion (Beers, 1975), embryonic tissue migra-
tions (Strickland et al., 1976) and inflam-
mation (Vassalli & Reich, 1977). Thus
although there is considerable evidence,
including the present paper, suggestive of
a functional correlation between plas-
minogen activation and some features of
transformation and malignancy, this cor-
relation is not exclusive.
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